These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 36253382)

  • 1. Generalizable deep learning model for early Alzheimer's disease detection from structural MRIs.
    Liu S; Masurkar AV; Rusinek H; Chen J; Zhang B; Zhu W; Fernandez-Granda C; Razavian N
    Sci Rep; 2022 Oct; 12(1):17106. PubMed ID: 36253382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer's disease.
    Liu M; Li F; Yan H; Wang K; Ma Y; ; Shen L; Xu M
    Neuroimage; 2020 Mar; 208():116459. PubMed ID: 31837471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting long-term progression of Alzheimer's disease using a multimodal deep learning model incorporating interaction effects.
    Wang Y; Gao R; Wei T; Johnston L; Yuan X; Zhang Y; Yu Z;
    J Transl Med; 2024 Mar; 22(1):265. PubMed ID: 38468358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of an interpretable deep learning framework for Alzheimer's disease classification.
    Qiu S; Joshi PS; Miller MI; Xue C; Zhou X; Karjadi C; Chang GH; Joshi AS; Dwyer B; Zhu S; Kaku M; Zhou Y; Alderazi YJ; Swaminathan A; Kedar S; Saint-Hilaire MH; Auerbach SH; Yuan J; Sartor EA; Au R; Kolachalama VB
    Brain; 2020 Jun; 143(6):1920-1933. PubMed ID: 32357201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-driven domain generalization for neuroimaging-based assessment of Alzheimer's disease.
    Lteif D; Sreerama S; Bargal SA; Plummer BA; Au R; Kolachalama VB
    Hum Brain Mapp; 2024 Jun; 45(8):e26707. PubMed ID: 38798082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated classification of Alzheimer's disease and mild cognitive impairment using a single MRI and deep neural networks.
    Basaia S; Agosta F; Wagner L; Canu E; Magnani G; Santangelo R; Filippi M;
    Neuroimage Clin; 2019; 21():101645. PubMed ID: 30584016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated MRI-Based Deep Learning Model for Detection of Alzheimer's Disease Process.
    Feng W; Halm-Lutterodt NV; Tang H; Mecum A; Mesregah MK; Ma Y; Li H; Zhang F; Wu Z; Yao E; Guo X
    Int J Neural Syst; 2020 Jun; 30(6):2050032. PubMed ID: 32498641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hybrid Convolutional and Recurrent Neural Network for Hippocampus Analysis in Alzheimer's Disease.
    Li F; Liu M;
    J Neurosci Methods; 2019 Jul; 323():108-118. PubMed ID: 31132373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer learning for predicting conversion from mild cognitive impairment to dementia of Alzheimer's type based on a three-dimensional convolutional neural network.
    Bae J; Stocks J; Heywood A; Jung Y; Jenkins L; Hill V; Katsaggelos A; Popuri K; Rosen H; Beg MF; Wang L;
    Neurobiol Aging; 2021 Mar; 99():53-64. PubMed ID: 33422894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A deep learning model for early prediction of Alzheimer's disease dementia based on hippocampal magnetic resonance imaging data.
    Li H; Habes M; Wolk DA; Fan Y;
    Alzheimers Dement; 2019 Aug; 15(8):1059-1070. PubMed ID: 31201098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A parallel attention-augmented bilinear network for early magnetic resonance imaging-based diagnosis of Alzheimer's disease.
    Guan H; Wang C; Cheng J; Jing J; Liu T
    Hum Brain Mapp; 2022 Feb; 43(2):760-772. PubMed ID: 34676625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET.
    Etminani K; Soliman A; Davidsson A; Chang JR; Martínez-Sanchis B; Byttner S; Camacho V; Bauckneht M; Stegeran R; Ressner M; Agudelo-Cifuentes M; Chincarini A; Brendel M; Rominger A; Bruffaerts R; Vandenberghe R; Kramberger MG; Trost M; Nicastro N; Frisoni GB; Lemstra AW; van Berckel BNM; Pilotto A; Padovani A; Morbelli S; Aarsland D; Nobili F; Garibotto V; Ochoa-Figueroa M
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):563-584. PubMed ID: 34328531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the progression of mild cognitive impairment to Alzheimer's disease by longitudinal magnetic resonance imaging-based dictionary learning.
    Lin Y; Huang K; Xu H; Qiao Z; Cai S; Wang Y; Huang L;
    Clin Neurophysiol; 2020 Oct; 131(10):2429-2439. PubMed ID: 32829290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal shape and asymmetry analysis by cascaded convolutional neural networks for Alzheimer's disease diagnosis.
    Li A; Li F; Elahifasaee F; Liu M; Zhang L;
    Brain Imaging Behav; 2021 Oct; 15(5):2330-2339. PubMed ID: 33398778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting progression from mild cognitive impairment to Alzheimer's disease on an individual subject basis by applying the CARE index across different independent cohorts.
    Chen J; Chen G; Shu H; Chen G; Ward BD; Wang Z; Liu D; Antuono PG; Li SJ; Zhang Z;
    Aging (Albany NY); 2019 Apr; 11(8):2185-2201. PubMed ID: 31078129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatio-temporal convolution for classification of alzheimer disease and mild cognitive impairment.
    Turhan G; Küçük H; Isik EO
    Comput Methods Programs Biomed; 2022 Jun; 221():106825. PubMed ID: 35636355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing variations in multi-center Alzheimer's disease classification with convolutional adversarial autoencoder.
    Cobbinah BM; Sorg C; Yang Q; Ternblom A; Zheng C; Han W; Che L; Shao J
    Med Image Anal; 2022 Nov; 82():102585. PubMed ID: 36057187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of mild cognitive impairment and Alzheimer's disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry.
    Sørensen L; Igel C; Pai A; Balas I; Anker C; Lillholm M; Nielsen M;
    Neuroimage Clin; 2017; 13():470-482. PubMed ID: 28119818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.